ERBB2 and breast carcinoma: From this classification it was derived the currently adopted subdivision at clinical level of breast cancer in five subtypes that involve luminal A-like, luminal B-like/HER2-negative, luminal B-like/HER2-positive, HER2-enriched, non-luminal, and triple-negative.